We purified from rat brain a novel actin filament (F-actin)–binding protein of ∼180 kD (p180), which was specifically expressed in neural tissue. We named p180 neurabin (neural tissue–specific F-actin– binding protein). We moreover cloned the cDNA of neurabin from a rat brain cDNA library and characterized native and recombinant proteins. Neurabin was a protein of 1,095 amino acids with a calculated molecular mass of 122,729. Neurabin had one F-actin–binding domain at the NH2-terminal region, one PSD-95, DlgA, ZO-1–like domain at the middle region, a domain known to interact with transmembrane proteins, and domains predicted to form coiled-coil structures at the COOH-terminal region. Neurabin bound along the sides of F-actin and showed F-actin–cross-linking activity. Immunofluorescence microscopic analysis revealed that neurabin was highly concentrated in the synapse of the developed neurons. Neurabin was also concentrated in the lamellipodia of the growth cone during the development of neurons. Moreover, a study on suppression of endogenous neurabin in primary cultured rat hippocampal neurons by treatment with an antisense oligonucleotide showed that neurabin was involved in the neurite formation. Neurabin is a candidate for key molecules in the synapse formation and function.
Skip Nav Destination
Article navigation
17 November 1997
Article|
November 17 1997
Neurabin: A Novel Neural Tissue–specific Actin Filament–binding Protein Involved in Neurite Formation
Hiroyuki Nakanishi,
Hiroyuki Nakanishi
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Hiroshi Obaishi,
Hiroshi Obaishi
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Ayako Satoh,
Ayako Satoh
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Manabu Wada,
Manabu Wada
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Kenji Mandai,
Kenji Mandai
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Keiko Satoh,
Keiko Satoh
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Hideo Nishioka,
Hideo Nishioka
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Yoshiharu Matsuura,
Yoshiharu Matsuura
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Akira Mizoguchi,
Akira Mizoguchi
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Yoshimi Takai
Yoshimi Takai
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Search for other works by this author on:
Hiroyuki Nakanishi
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Hiroshi Obaishi
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Ayako Satoh
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Manabu Wada
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Kenji Mandai
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Keiko Satoh
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Hideo Nishioka
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Yoshiharu Matsuura
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Akira Mizoguchi
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Yoshimi Takai
*Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co., Ltd., Nishi-ku, Kobe 651-22, Japan; ‡Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan; §Department of Virology II, National Institutes of Health, Tokyo 162, Japan; ‖Department of Anatomy and Neurobiology, Graduate School, Kyoto University, Kyoto 606-01, Japan
Address all correspondence to Y. Takai, Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565, Japan. Tel.: 81-6-879-3410. Fax: 81-6-879-3419. E-mail: [email protected]
Received for publication 7 April 1997 and in revised form 8 August 1997.
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 139 (4): 951–961.
Citation
Hiroyuki Nakanishi, Hiroshi Obaishi, Ayako Satoh, Manabu Wada, Kenji Mandai, Keiko Satoh, Hideo Nishioka, Yoshiharu Matsuura, Akira Mizoguchi, Yoshimi Takai; Neurabin: A Novel Neural Tissue–specific Actin Filament–binding Protein Involved in Neurite Formation . J Cell Biol 17 November 1997; 139 (4): 951–961. doi: https://doi.org/10.1083/jcb.139.4.951
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement